Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy.
Jae Kwang YunSugyeong KimHongyul AnGeun Dong LeeHyeong Ryul KimYong-Hee KimDong Kwan KimSeung-Il ParkSehoon ChoiYoungil KohPublished in: Genome medicine (2023)
In resected NSCLC, existence of preoperative CH might amplify CH-related adverse outcomes through adjuvant treatments, resulting in poor survival results.